ORANGE COUNTY EARNINGS

NeoTherapeutics Inc.: The Irvine drug development company posted a net loss of $2.6 million, or 47 cents a share, for the second quarter, compared with a net loss of $1.2 million, or 23 cents a share, for the second quarter of 1997. For the six months, a net loss of $5.1 million, or 93 cents a share, was reported, compared with a net loss of $2 million, or 38 cents a share, for the 1997 first half. The company said that increased expenditures for research and development contributed to the higher losses for the 1998 period.